Analysis of curative effect and drug tolerance in the treatment of severe bacterial oculopathy by levofloxacin
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To evaluate the curative effect and drug tolerance in the treatment of severe bacterial keratitis and conjunctivitis by levofloxacin.

    METHODS: Totally 195 patients with severe bacterial keratitis and conjunctivitis were included in this study. Based on the sequence of enrollment, they were randomly divided into three groups: group A(65 patients)received levofloxacin, group B(65 patients)received suture method under microscope, group C received suture method with loupe besides the same basic operative treatment in the two groups. The curative effect and drug tolerance were observed and compared statistically.

    RESULTS: In group A, 54 cases were cured, in the rate of 83.1%, 7 cases(10.8%)were excellent, 3 cases(4.6%)were valid, 1 case(1.5%)was invalid. In group B, 25 cases(38.5%)were cured, 6 cases(9.2%)were excellent, 23 cases(35.4%)were valid, 11 cases(16.9%)were invalid. In group C, 4 cases(6.2%)were cured, 3 cases(4.6%)were excellent, 36 cases(55.4%)were valid, 22 cases(33.8%)were invalid. The curative effect and drug tolerance among groups had obvious differences(P<0.05).

    CONCLUSION: Levofloxaoin is effective and safe for the treatment of bacterial conjunctivitis and keratitis, which is not resistant and worthy of promotion.

    Reference
    Related
    Cited by
Get Citation

Su-Hua Xiao. Analysis of curative effect and drug tolerance in the treatment of severe bacterial oculopathy by levofloxacin. Guoji Yanke Zazhi( Int Eye Sci) 2014;14(9):1707-1709

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:April 10,2014
  • Revised:August 04,2014
  • Adopted:
  • Online: August 19,2014
  • Published: